News archive сентябрь 2006

Animal health care company Vet Biotechnology reports that they have launched cutting edge technology in Australia with the collection of equine umbilical cord stem cells from the afterbirth of newborn thoroughbred foals.

Testing to Begin by Year-End, With Clinical Human Trials to Follow As Soon As Possible

Canadian scientists are investigating a novel way of treating a deadly form of leukemia: By targeting the stem cells that allow the cancer to return after chemotherapy has resulted in apparent remission.

Using stem cells harvested from patients' own bone marrow, researchers reported Wednesday that they improved cardiac function in heart-attack patients months, years — even decades — after the patients suffered their attacks.

A company that said it had developed a less controversial way to produce human embryonic stem cells and an academic institute that also makes stem cells announced on Tuesday they would team up to distribute the valued cells.

The journal STEM CELLS® announced that scientists were able, for the first time, to derive pluripotent human embryonic stem cells (hESCs) from non-viable early human embryos.

Five kinds of tissue, including bone, blood vessels, fat and nerve cells, have been made from adult stem cells taken from pig blood.

Procedures using stem cells derived from human embryos could be utilized in a few years to repair disease-damaged retinas, new research by University of Washington scientists indicates.

A new study in the open access journal PLoS Medicine suggests that developing countries could benefit enormously from the new field of regenerative medicine, in which treatments are being developed from stem cells.

An approach proven to cure a rat model of type 1 or juvenile-onset diabetes also works in a rat model of type 2 or adult-onset diabetes, according to a new report from researchers at Washington University School of Medicine in St. Louis.

A new way of promoting healing when fractured bones refuse to mend, has been pioneered at a British hospital, saving patients permanent disability or amputation.

The critical gene, already well known for its role in suppressing tumors, seems to mediate a profound balance between life and death. It weighs the generation of new replacement cells, required for continued life, against the risk of death from cancer, which is the inevitable outcome of letting cells divide. To offset the increasing risk of cancer as a person ages, the gene gradually reduces the ability of stem cells to proliferate.

Living Cell Technologies Ltd today announced it has lodged an application with the New Zealand regulator MedSafe to conduct a Phase I/IIa clinical trial of its type 1 diabetes cell therapy product DiabeCell.

For athletes, stem cells have much more than the potential to cure disease and save lives -- they may be able to heal injuries, boost strength and endurance, and provide a lasting edge over the competition.

Researchers from the Swiss Institute for Experimental Cancer Research (ISREC) have shown that a single gene involved in embryonic development is responsible for two seemingly contradictory activities -- maintaining stem cells after the embryo has implanted in the mother's uterus, and later providing cues to direct their differentiation in a coordinated fashion when the time is ripe.

What's believed to be Canada's first stem-cell treatment for horses has been conducted in southern Alberta.